
Imagion Biosystems Files IND with FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
Imagion Biosystems Advances Precision Cancer Imaging with FDA IND Filing for MagSense® Phase 2 Trial Imagion Biosystems, a molecular imaging company focused on transforming cancer detection and diagnosis, has announced a significant regulatory milestone with the submission of an Investigational…












